# First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration

> **NCT02076919** · PHASE1 · COMPLETED · sponsor: **Alcon Research** · enrollment: 110 (actual)

## Conditions studied

- Age-Related Macular Degeneration

## Interventions

- **DRUG:** LHA510 Ophthalmic Suspension
- **DRUG:** LHA510 Vehicle

## Key facts

- **NCT ID:** NCT02076919
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2016-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02076919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02076919, "First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02076919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*